Home Your basket
• Spontaneous perforation i...
   Price 8.50 €
• The silent sinus syndrome...
   Price 12.50 €
• Is HIV/AIDS an independen...
   Price 10.50 €
• Acute rhinosinusitis in a...
   Price 8.50 €
• Multi-factorial analysis ...
   Price 10.50 €
• Social consequence of a d...
   Price 10.50 €
• An original case of laryn...
   Price 8.50 €
• Role and importance of pH...
   Price 12.00 €
• Giant osteoma of the maxi...
   Price 8.50 €
• Middle ear adenoma / carc...
   Price 8.50 €
• Inverted naso-sinus papil...
   Price 10.50 €
• Clinical signs and correl...
   Price 10.50 €
• Role of positron emission...
   Price 15.00 €
• Vertical extended hemi cr...
   Price 5.50 €
• Intrapetrous cholesteatom...
   Price 10.50 €
• Usher type I syndrome in ...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Dehiscence of the anterio...
   Price 8.50 €
• The rehabilitation of the...
   Price 10.50 €
• Moderate leukocyte infilt...
   Price 10.50 €
• The subjective visual ver...
   Price 10.50 €
• Newborn and infant nasal ...
   Price 5.50 €
• Different clinical approa...
   Price 5.50 €
• Mucoepidermoid carcinomas...
   Price 10.50 €
• Benign paroxysmal positio...
   Price 10.50 €
• Quality of life after oro...
   Price 10.50 €
• Kikuchi-Fujimoto’s diseas...
   Price 10.50 €
• Cervico facial lymphangio...
   Price 10.50 €
• Marginal indications for ...
   Price 12.50 €
• Eagle syndrom: A case rep...
   Price 8.50 €
• Bell's palsy: treatment b...
   Price 5.50 €
• Parathyroid carcinoma: di...
   Price 5.50 €
• Carcinogenesis of the eth...
   Price 10.50 €
• Mucosal melanomas of the ...
   Price 8.50 €
• Dysphagia, a geriatric po...
   Price 8.50 €
• Clinical implementation o...
   Price 5.50 €

Total Order 338.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2010 o

PHONIATRICS

Voice related quality of life after botulinum toxin injection for spasmodic dysphonia


Authors : Gama A. C. C. 1<br />Menezes LN, Maia AA, Rezende Neto AL, Oliveira JB. (Belo Horizonte)

Ref. : Rev Laryngol Otol Rhinol. 2010;131,1:39-44.

Article published in english
Downloadable PDF document english



Summary : Introduction: Laryngeal Focal Dystonia (LFD) leads to a type of voice with a strained and tense quality which has a neurological origin, affecting the social-emotional realms of the individuals, and their quality of life. Aims: Measure the voice-related quality of life of patients with Adductor LFD pre and post-treatment with Botox®‚ injection followed by voice therapy, using the Voice-Related Quality of Life (V-RQOL). Study Design: Prospective study. Methods: Adductor 11 female patients aged between 33 and 74 years with a diagnosis of Adductor LFD were evaluated. All patients underwent a neurological evaluation. Laryngoscopy was performed with both rigid and flexible endoscopes. Speech and Language evaluation followed the Evaluation of Voice Protocol, proposed by Behlau, Pontes (1995). The American V-RQOL measure was utilized. Results: Statistical analysis demonstrated significant difference (p< 0,05). 81.8% of patients showed higher scores post-Botox®‚ for the social-emotional and physical domain. In the overall V-RQOL scores 72.7% of patients showed greater scores post-treatment. Conclusions: There was an improvement in the quality of life for these patients post-treatment. The V-RQOL proved to be an efficient tool to measure the treatment outcomes of LFD pre and post botulinum toxin injection.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE